ATE84217T1 - Fragmente und fraktionen von heparin mit wirkung gegen hiv. - Google Patents

Fragmente und fraktionen von heparin mit wirkung gegen hiv.

Info

Publication number: ATE84217T1
Authority: AT; Austria
Prior art keywords: hiv; fractions; fragments; active anti; heparin
Prior art date: 1988-08-24

Application number

AT89202061T

Other languages

English (en)

Inventor

Henricus Carl J Ottenheijm

Franciscus C Den Hollander

Erik Desire A De Clercq

Original Assignee

Akzo Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-08-24

Filing date

1989-08-09

Publication date

1993-01-15

1989-08-09 Application filed by Akzo Nv filed Critical Akzo Nv

1993-01-15 Application granted granted Critical

1993-01-15 Publication of ATE84217T1 publication Critical patent/ATE84217T1/de

Links

HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 title 1
230000036436 anti-hiv Effects 0.000 title 1
239000012634 fragment Substances 0.000 title 1
229960002897 heparin Drugs 0.000 title 1
229920000669 heparin Polymers 0.000 title 1
241000725303 Human immunodeficiency virus Species 0.000 abstract 2
239000004019 antithrombin Substances 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
239000002565 heparin fraction Substances 0.000 abstract 1
239000002634 heparin fragment Substances 0.000 abstract 1
230000010076 replication Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
- C08B37/0078—Degradation products

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Materials Engineering (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Polymers & Plastics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Compounds Of Unknown Constitution (AREA)
Medicines Containing Plant Substances (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)

AT89202061T 1988-08-24 1989-08-09 Fragmente und fraktionen von heparin mit wirkung gegen hiv. ATE84217T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
NL8802087		1988-08-24
EP89202061A EP0355905B1 (de)	1988-08-24	1989-08-09	Fragmente und Fraktionen von Heparin mit Wirkung gegen HIV

Publications (1)

Publication Number	Publication Date
ATE84217T1 true ATE84217T1 (de)	1993-01-15

Family

ID=19852794

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT89202061T ATE84217T1 (de)	1988-08-24	1989-08-09	Fragmente und fraktionen von heparin mit wirkung gegen hiv.

Country Status (13)

Country	Link
EP (1)	EP0355905B1 (de)
JP (1)	JPH02108624A (de)
KR (1)	KR0143084B1 (de)
AT (1)	ATE84217T1 (de)
AU (1)	AU617850B2 (de)
CA (1)	CA1330305C (de)
DE (1)	DE68904264T2 (de)
DK (1)	DK416089A (de)
ES (1)	ES2053953T3 (de)
IE (1)	IE61565B1 (de)
NZ (1)	NZ230394A (de)
PT (1)	PT91524B (de)
ZA (1)	ZA896231B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH08109134A (ja) *	1994-10-11	1996-04-30	Sanwa Kagaku Kenkyusho Co Ltd	細胞変成抑制並びに臓器毒性軽減剤
US5744457A (en) *	1995-03-31	1998-04-28	Hamilton Civic Hospitals Research Development Inc.	Compositions and methods for inhibiting thrombogenesis
US5763427A (en) *	1995-03-31	1998-06-09	Hamilton Civic Hospitals Research Development Inc.	Compositions and methods for inhibiting thrombogenesis
US6001820A (en) *	1995-03-31	1999-12-14	Hamilton Civic Hospitals Research Development Inc.	Compositions and methods for inhibiting thrombogenesis
EP0735050B1 (de) *	1995-03-31	2002-09-25	Hamilton Civic Hospitals Research Development, Inc.	Zusammensetzung zur Hemmung der Thromboseentstehung
US5767269A (en) *	1996-10-01	1998-06-16	Hamilton Civic Hospitals Research Development Inc.	Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
DE19836339B4 (de)	1998-08-11	2011-12-22	N.V. Nutricia	Kohlenhydratmischung
AU2002214886A1 (en) *	2000-11-09	2002-05-21	Contrimmune Biotechnology Inc	Therapeutic uses for IP3 receptor-mediated calcium channel modulators
FR2838649B1 (fr) *	2002-04-19	2006-01-13	Commissariat Energie Atomique	Composition anti-vih, procede de fabrication et medicament
US20040229778A1 (en) *	2003-05-13	2004-11-18	Elmaleh David R.	Pharmaceutical compositions of antithrombin III for the treatment of retroviral diseases
EP1597978A1 (de)	2004-05-17	2005-11-23	Nutricia N.V.	Synergie von GOS und polyfruktose
US8252769B2 (en)	2004-06-22	2012-08-28	N. V. Nutricia	Intestinal barrier integrity
EP1721611A1 (de) *	2005-04-21	2006-11-15	N.V. Nutricia	Nahrungsergänzungspräparat mit Oligosacchariden für eine Kategorie von HIV Patienten
WO2011002027A1 (ja)	2009-07-03	2011-01-06	テイ・エステック株式会社	乗物用シート
MX2013002556A (es)	2010-09-14	2013-05-28	Hoffmann La Roche	Polipeptido de fusion de dedo de serpina.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3422518A1 (de) *	1984-06-16	1985-12-19	B. Braun Melsungen Ag, 3508 Melsungen	Heparin-derivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung bei der behandlung von fettstoffwechselstoerungen
ZA878877B (en) *	1986-11-29	1988-05-24	Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo	Treatment of diseases caused by viruses
AU4426289A (en) *	1988-10-05	1990-05-01	Nicola Diferrante	Methods for interfering with hiv multiplication and composition for the treatment of aids

1989
- 1989-08-09 IE IE256589A patent/IE61565B1/en not_active IP Right Cessation
- 1989-08-09 EP EP89202061A patent/EP0355905B1/de not_active Expired - Lifetime
- 1989-08-09 AT AT89202061T patent/ATE84217T1/de not_active IP Right Cessation
- 1989-08-09 ES ES89202061T patent/ES2053953T3/es not_active Expired - Lifetime
- 1989-08-09 DE DE8989202061T patent/DE68904264T2/de not_active Expired - Fee Related
- 1989-08-15 ZA ZA896231A patent/ZA896231B/xx unknown
- 1989-08-17 AU AU40012/89A patent/AU617850B2/en not_active Ceased
- 1989-08-21 KR KR1019890011856A patent/KR0143084B1/ko not_active Expired - Fee Related
- 1989-08-22 NZ NZ230394A patent/NZ230394A/en unknown
- 1989-08-23 DK DK416089A patent/DK416089A/da not_active Application Discontinuation
- 1989-08-23 CA CA000609119A patent/CA1330305C/en not_active Expired - Fee Related
- 1989-08-23 JP JP1217165A patent/JPH02108624A/ja active Pending
- 1989-08-23 PT PT91524A patent/PT91524B/pt not_active IP Right Cessation

Also Published As

Publication number	Publication date
IE61565B1 (en)	1994-11-16
IE892565L (en)	1990-02-24
PT91524B (pt)	1995-07-18
KR900002788A (ko)	1990-03-23
DE68904264T2 (de)	1993-05-27
DK416089D0 (da)	1989-08-23
AU617850B2 (en)	1991-12-05
NZ230394A (en)	1997-02-24
CA1330305C (en)	1994-06-21
PT91524A (pt)	1990-03-08
KR0143084B1 (ko)	1998-07-15
JPH02108624A (ja)	1990-04-20
AU4001289A (en)	1990-03-01
EP0355905B1 (de)	1993-01-07
ZA896231B (en)	1990-05-30
ES2053953T3 (es)	1994-08-01
DE68904264D1 (de)	1993-02-18
DK416089A (da)	1990-02-25
EP0355905A1 (de)	1990-02-28

Similar Documents

Publication	Publication Date	Title
ATE84217T1 (de)	1993-01-15	Fragmente und fraktionen von heparin mit wirkung gegen hiv.
ATE264914T1 (de)	2004-05-15	Antivirale proteine, dafür kodierende dna, und deren verwendung
FI952302L (fi)	1995-05-11	Pyran-2-onit ja 5,6-dihydropyranonit, jotka ovat käyttökelpoisia HIV:n ja muiden retrovirusten hoidossa
FR2650598B1 (fr)	1994-06-03	Derives de l'albumine a fonction therapeutique
ES2130114T3 (es)	1999-07-01	5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepinas y su uso en la prevencion o tratamiento de infeccion por hiv.
ATE100098T1 (de)	1994-01-15	Nukleoside, ihre herstellung und pharmazeutische zusammenstellungen.
ES2123048T3 (es)	1999-01-01	Analogos de nucleosidos antiviricos.
ATE132163T1 (de)	1996-01-15	Neue polypeptide und damit hergestellte anti-hiv medikamente
DK538888D0 (da)	1988-09-28	Anvendelse af castanosperminestere til fremstilling af et farmaceutisk praeparat
GR1000419B (el)	1992-06-30	Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου.
DE69023708D1 (de)	1996-01-04	Anti-hiv-heilmittel.
EP0311107A3 (de)	1990-04-18	Anti-HIV-aktive 3'-Fluoro-purin-2',3'-dideoxyriboside
DE68914990D1 (de)	1994-06-01	Verfahren zur inhibierung der wirkung des menschlichen immunschwäche-virus (hiv) in vivo.
ATE152717T1 (de)	1997-05-15	Gegen viren wirksame naphtochinon-verbindungen, zusammensetzungen und deren verwendungen
ATE58478T1 (de)	1990-12-15	Zubereitungen und verfahren zum schutz von tlymphozyten gegen das krankheitsagens von lymphadenopathie und vom erworbenen immundepressionsyndrom.
ES2108680T3 (es)	1998-01-01	Uso del derivado n-n-butilo de desoxinojirimicina en la fabricacion de un medicamento.
AU2833789A (en)	1989-07-13	Non-reverting rna viruses
AU2880595A (en)	1996-01-25	Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
KR950702838A (ko)	1995-08-23	인터루킨-4(IL-4)를 사용한 사람 면역결핍 바이러스(HIV) 복제의 억제방법(Method for inhibiting HIV replication using IL-4)
WO1990005523A3 (en)	1990-07-12	Phenanthrolinedicarboxylate esters, 4-aminoquinoline and isoquinoline derivatives as inhibitors of hiv reverse transcriptase
KR890006665A (ko)	1989-06-15	항-hiv 활성, 3'-아지도-2,6-디아미노푸린-2',3'-디데옥시리보사이드
BR0007627A (pt)	2002-04-09	Mutações de hiv-1 selecionadas por beta-2', 3' -didehidro-2', 3' -didesóxi-5-fluorocitidina
FI883735A7 (fi)	1989-02-15	Ihmisen immuunikatoviruksen, tyyppi 1, antigeenien valmistus ja käyttö diagnostisena ja terapeuttisena välineenä
ATE185485T1 (de)	1999-10-15	Arzneimittel zur verhinderung einer infektion mit dem für aids verantwortlichen virus
DE68908757D1 (de)	1993-10-07	5-Methoxypsoralen gegen Depressionen.

Legal Events

Date	Code	Title	Description
1999-05-15	REN	Ceased due to non-payment of the annual fee